Leading Plasma Donation Companies in South Korea | Key Player 2026

Leading Plasma Donation Companies in South Korea

The following is a data-backed list of the leading South Korea Plasma Donation companies, compiled through 6Wresearch's proprietary research and validated by in-house industry analysts. These companies represent the key players shaping competition in the South Korea Plasma Donation Industry, including SK Plasma, Green Cross (GC Biopharma), and other established names.

List of Plasma Donation companies in South Korea:

1. SK Plasma

SK Plasma is the domestic leader in blood plasma-derived products, leveraging advanced fractionation technology to export essential therapies globally.

2. Green Cross (GC Biopharma)

GC Biopharma is a pioneer in the plasma protein sector, holding a dominant position in the production of immunoglobulins and coagulation factor treatments.

3. Hanmi Pharmaceutical

Hanmi invests heavily in bio-therapeutics and collaborative R&D to enhance the stability and efficacy of plasma-derived protein treatments.

4. Dong-A ST

Dong-A ST focuses on specialized medicine and works to integrate plasma-related biopharmaceutical solutions into its broad medical portfolio.

5. JW Holdings

JW Holdings provides a robust infrastructure for medical supplies and fluid therapy, integrating plasma components into modern clinical practice.

6. Daewoong Pharmaceutical

Daewoong utilizes cutting-edge bio-manufacturing to support the stability of medical supply chains, including critical plasma-derived protein therapeutics.

7. Il-Yang Pharmaceutical

Il-Yang specializes in innovative drug development and contributes to the diversification of the Korean biopharmaceutical raw material landscape.

8. Celltrion

Celltrion’s massive bio-manufacturing capacity sets the standard for high-purity protein production in Korea.

9. Samsung Biologics

Samsung Biologics provides the technical backbone for complex protein processing, essential for high-end plasma fractionation.

10. Boryung

Boryung plays a crucial role in distributing health-critical pharmaceutical ingredients and supporting national medical stability programs.

Frequently Asked Questions About the Market Study (FAQs):